Novartis Publishes eBook of Meningococcal Disease Survivors

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-05-07-2014
Volume 10
Issue 5

Novartis' eBook features images of meningococcal disease survivors from around the world.

Novartis, in partnership with photographer Anne Geddes, the Confederation of Meningitis Organizations (CoMO), and charities around the world, have published an eBook featuring inspirational images of meningococcal disease survivors from around the world who have participated in the Protecting Our Tomorrows: Portraits of Meningococcal Disease campaign. This project aims to raise public awareness of meningococcal disease and the importance of vaccination. The eBook is available to download on iBooks.

"Through a series of what I believe are inspirational photographs of meningococcal disease survivors and families impacted by the disease, this project celebrates the survivors' triumphs and honors those who've tragically lost their lives," said Geddes. "Over my 30-year career, there is not one parent I have worked with who doesn't love their children, want to nurture their children and protect their children. Through these images, I hope parents feel empowered to understand the disease's impact and know the options available to them."

The eBook is the culmination of a worldwide project launched in 2013, aiming to raise awareness of meningococcal disease. Geddes meet with the 15 project participants from eight countries (Australia, Canada, Brazil, Germany, Ireland, Spain, UK, and US) to depict their resilience through their portraits. As global project ambassador, Geddes has also worked to promote awareness and encourage meningococcal disease education through meetings with journalists, patient advocacy organizations, and public officials.

Source: Novartis

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content